Clinical and epidemiological characteristics, morbidity and treatment based on the registry of acromegalic patients in Colombia: RAPACO

IF 1.6 4区 医学 Q4 CELL BIOLOGY
Rafael Castellanos-Bueno , Alín Abreu-Lomba , Nathalia Buitrago-Gómez , Marcela Patiño-Arboleda , Doly Pantoja-Guerrero , Alex Valenzuela-Rincón , Henry M. Arenas-Quintero , Humberto I. Franco-Betancur , Alejandro Castellanos-Pinedo , Dinett Movilla-Castro , José M. Ocampo-Chaparro , Carlos A. Reyes-Ortiz , Alejandro Pinzón-Tovar
{"title":"Clinical and epidemiological characteristics, morbidity and treatment based on the registry of acromegalic patients in Colombia: RAPACO","authors":"Rafael Castellanos-Bueno ,&nbsp;Alín Abreu-Lomba ,&nbsp;Nathalia Buitrago-Gómez ,&nbsp;Marcela Patiño-Arboleda ,&nbsp;Doly Pantoja-Guerrero ,&nbsp;Alex Valenzuela-Rincón ,&nbsp;Henry M. Arenas-Quintero ,&nbsp;Humberto I. Franco-Betancur ,&nbsp;Alejandro Castellanos-Pinedo ,&nbsp;Dinett Movilla-Castro ,&nbsp;José M. Ocampo-Chaparro ,&nbsp;Carlos A. Reyes-Ortiz ,&nbsp;Alejandro Pinzón-Tovar","doi":"10.1016/j.ghir.2021.101425","DOIUrl":null,"url":null,"abstract":"<div><h3>Aims</h3><p>Describe the local characteristics, methodology and results of the registry of acromegalic patients in Colombia (RAPACO).</p></div><div><h3>Methods</h3><p>Multicenter, retrospective study based on the registry of acromegalic patients in Colombia: RAPACO. The data collected included: demographics, diagnosis, approximate time of disease evolution, data on weight, height, body mass index<span><span> (BMI), neck circumference<span> (NC) abdominal circumference<span> (AC) hip circumference (HC) and waist/hip ratio (WHR); clinical and biochemical data at the time of diagnosis, etiology, </span></span></span>immunohistochemistry<span> of the tumor and information related to types of treatment. Descriptive analytics were employed.</span></span></p></div><div><h3>Results</h3><p>A total of 201 patients (60% females) with an average age at registration of 49.5 ± 14.6 years and an average time of evolution of the disease of 6.96 ± 4.5 years. Average weight was 75.1 Kg ± 12.98, with an average BMI of 28.11 ± 4.33. The most frequent symptoms mentioned at the time of diagnosis were extremity enlargement and headache. The most frequent comorbidity was arterial hypertension in 50.3% of the cases. 78.6% of cases were caused by macroadenoma<span>. 80.1% received surgical treatment, 77.6% were under medical treatment, of which 95.7% were receiving somatostatin analogues. 26.4% of patients were treated with radiation therapy. Of the patients who received any type of clinical treatment, only 2.5% reported biochemical control at registration.</span></p></div><div><h3>Conclusion</h3><p>It is important to recognize the local epidemiological, clinical, biochemical and treatment characteristics in order to assist in further understanding this pathology to implement local measures to improve both the quality of life as well as the prognosis of the patients diagnosed.</p></div>","PeriodicalId":12803,"journal":{"name":"Growth Hormone & Igf Research","volume":"60 ","pages":"Article 101425"},"PeriodicalIF":1.6000,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ghir.2021.101425","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Growth Hormone & Igf Research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1096637421000484","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 2

Abstract

Aims

Describe the local characteristics, methodology and results of the registry of acromegalic patients in Colombia (RAPACO).

Methods

Multicenter, retrospective study based on the registry of acromegalic patients in Colombia: RAPACO. The data collected included: demographics, diagnosis, approximate time of disease evolution, data on weight, height, body mass index (BMI), neck circumference (NC) abdominal circumference (AC) hip circumference (HC) and waist/hip ratio (WHR); clinical and biochemical data at the time of diagnosis, etiology, immunohistochemistry of the tumor and information related to types of treatment. Descriptive analytics were employed.

Results

A total of 201 patients (60% females) with an average age at registration of 49.5 ± 14.6 years and an average time of evolution of the disease of 6.96 ± 4.5 years. Average weight was 75.1 Kg ± 12.98, with an average BMI of 28.11 ± 4.33. The most frequent symptoms mentioned at the time of diagnosis were extremity enlargement and headache. The most frequent comorbidity was arterial hypertension in 50.3% of the cases. 78.6% of cases were caused by macroadenoma. 80.1% received surgical treatment, 77.6% were under medical treatment, of which 95.7% were receiving somatostatin analogues. 26.4% of patients were treated with radiation therapy. Of the patients who received any type of clinical treatment, only 2.5% reported biochemical control at registration.

Conclusion

It is important to recognize the local epidemiological, clinical, biochemical and treatment characteristics in order to assist in further understanding this pathology to implement local measures to improve both the quality of life as well as the prognosis of the patients diagnosed.

基于哥伦比亚肢端肥大症患者登记的临床和流行病学特征、发病率和治疗:RAPACO
目的描述哥伦比亚肢端肥大症患者(RAPACO)登记的地方特点、方法和结果。方法基于哥伦比亚肢端肥大症患者的多中心回顾性研究:RAPACO。收集的资料包括:人口统计学、诊断、疾病演变的大致时间、体重、身高、体重指数(BMI)、颈围(NC)、腹围(AC)、臀围(HC)和腰臀比(WHR);诊断时的临床生化资料、病因、肿瘤免疫组织化学及治疗类型相关信息。采用描述性分析。结果201例患者(女性占60%),登记时平均年龄49.5±14.6岁,平均发病时间6.96±4.5年。平均体重75.1 Kg±12.98,平均BMI 28.11±4.33。诊断时最常见的症状是四肢肿大和头痛。最常见的合并症是动脉高血压,占50.3%。78.6%的病例由大腺瘤引起。80.1%接受手术治疗,77.6%接受内科治疗,其中95.7%接受生长抑素类似物治疗。26.4%的患者接受了放射治疗。在接受任何类型临床治疗的患者中,只有2.5%在登记时报告生化控制。结论认识当地的流行病学、临床、生化和治疗特点,有助于进一步了解本病,实施当地措施,提高患者的生活质量和预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Growth Hormone & Igf Research
Growth Hormone & Igf Research 医学-内分泌学与代谢
CiteScore
3.30
自引率
0.00%
发文量
38
审稿时长
57 days
期刊介绍: Growth Hormone & IGF Research is a forum for research on the regulation of growth and metabolism in humans, animals, tissues and cells. It publishes articles on all aspects of growth-promoting and growth-inhibiting hormones and factors, with particular emphasis on insulin-like growth factors (IGFs) and growth hormone. This reflects the increasing importance of growth hormone and IGFs in clinical medicine and in the treatment of diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信